Yazar "Mercan, Sibel" seçeneğine göre listele
Listeleniyor 1 - 4 / 4
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe DEPRESSION, HOPELESSNESSAND SUICIDALITY IN PSORIASIS PATIENTS(Acta Dermato-Venereologica, 2019) Altunay, Ilknur Kivanc; Deniz, Fatma; Mercan, Sibel[Abstract Not Available]Öğe Dermatological and psychiatric manifestations in heroin and bonsai use disorder(Pacini Editore, 2020) Can, Yesim; Altunay, Ilknur Kivanc; Mercan, Sibel; Evren, Cuneyt; Pospos, Ozlem Helin; Ozkur, EzgiBackground: In in cases of substance use disorder (SUD), dermatological findings may provide significant information about the mental state of the patients involved. Awareness of cutaneous signs together with psychiatric manifestations may be an effective way to address the issue of treating substance use. Aims: This study aims to detect cutaneous signs and mental state of patients with heroin and bonsai use disorder through dermatological and psychiatric examinations. Methods: 156 male inpatients with SUD (heroin, n=104 and bonsai, n=52) were included. A standart personal information form, the Symptom Checklist-90-Revised (SCL-90-R) and the Drug Use Disorders Identification Test (DUDIT) were filled out by each patient. Assessment of patients' psychiatric condition and their dermatological examinations were performed by the same psychiatrists and the same dermatoalogist. Tattoos and self-inflicted scars (SIS), which were the result of self-harm behavior (SHB) were rated separately. Results: The most frequent and dramatic findings in all SUD cases were tattoos (n=70), SIS (n=64), traumatic scars (n=59), cutaneous infections (n=49), acne (n=42), and vascular lesions (n=18). Injection scars, and vascular lesions were detected at higher rates in heroin users, while acne lesions were significantly more frequent in bonsai users (p =.022). The rates recorderd for having tattoos were 32.7% (n=17) in bonsai users and 51% (n=53) in heroin users. The age of onset for first substance use, and regular substance use, besides the patients' age at first treatment were both lower in tattoo patients than in those without tattoos. From subscale scores of SCL 90-R, the somatization, depression, interpersonal sensitivity, anxiety scores were all higher in heroin users than in bonsai users. Conclusions: Physicians should be aware of dermatological clues in SUD patients. Evaluation of dermatological findings including tattoos is important in detecting SUD and obtaining information on the mental state of the patients.Öğe DERMATOLOGICAL MANIFESTATIONS IN HEROIN AND BONSAI USE DISORDER(Acta Dermato-Venereologica, 2019) Altunay, Ilknur Kivanc; Can, Yesim; Mercan, Sibel; Ozkur, Ezgi; Sekerlisoy, Gul[Abstract Not Available]Öğe Sexual dysfunction in women with human papilloma virus infection in the Turkish population(Taylor & Francis Inc, 2019) Mercan, Ramazan; Mercan, Sibel; Durmaz, Birsen; Sur, Haydar; Kilciksiz, Can Misel; Kacar, Anil Safak; Apaydin, ZuhalHuman papilloma virus infection (HPV) is the most common sexually transmitted disease. It may increase the risk of several cancers, including those of the cervix, vulva, vagina, head and neck. HPV is usually transmitted during sexual intercourse; there are limited data about sexual dysfunction (SD) after infection with this virus. We aimed to measure the incidence of SD in women with HPV. In this study, we evaluated 67 HPV-infected female patients and 66 healthy controls. The Arizona Sexual Experience Scale (ASEX), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI) and Socio Demographic Form were used for evaluation. Gynaecologists and psychiatrists evaluated the participants. Women with HPV were found to have significantly higher Arizona Sexual Experience Scale (ASEX) total scores and ASEX sub scores than the control group in the domains of sexual desire, arousal, genital response, orgasmic experience and their satisfaction from orgasm (p.05). The study group shows a statistically significant difference in the Beck Depression Inventory (BDI), but Beck Anxiety Inventory (BAI) scores show no significant differences between the experimental and control groups. Our study shows that HPV positivity in female patients is associated with a significant impairment in sexual function and that this impairment is not related to depression or anxiety.Impact statementWhat is already known on this subject? There are only a few studies concerned with sexual dysfunction in HPV patients. These studies have methodological problems, as they do not rule out the effect of depression on sexual dysfunction. It is very difficult to perform studies on sexual dysfunction and sexually transmitted diseases, because both physicians and patients are reluctant to talk about sexual problems. In the present study, only 6 out of 15 physicians accepted to contribute to the study. Although the physicians gave a questionnaire to more than 400 patients, only 133 of them completed that questionnaire. The most important difficulties in this study was to find enough patients.What do the results of this study add? Depression and sexual dysfunction are frequently seen in HPV patients. Although depression is one of the most common causes of sexual dysfunction, an HPV infection may lead to sexual dysfunction even in the patients without depression.What are the implications of these findings for clinical practice and/or further research? HPV infections may be associated with mental health problems and sexual dysfunction. The gynaecologists and other clinicians working with HPV patients should also evaluate patients psychologically and refer patients to psychiatry if required. The psychiatric problems associated with an HPV infection do not only impair sexual functions, but also may lead to difficulties in social life.
